Skip to main content
International Journal of Physiology, Pathophysiology and Pharmacology logoLink to International Journal of Physiology, Pathophysiology and Pharmacology
. 2014 Jul 12;6(2):125–136.

Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities

Arshad H Rahmani 1, Fahad M Al shabrmi 2, Salah M Aly 1,3
PMCID: PMC4106649  PMID: 25057339

Abstract

The current mode of treatment based on synthetic drugs is expensive and also causes genetic and metabolic alterations. However, safe and sound mode of treatment is needed to control the diseases development and progression. In this regards, medicinal plant and its constituents play an important role in diseases management via modulation of biological activities. Ginger, the rhizome of the Zingiber officinale, has shown therapeutic role in the health management since ancient time and considered as potential chemopreventive agent. Numerous studies based on clinical trials and animal model has shown that ginger and its constituents shows significant role in the prevention of diseases via modulation of genetic and metabolic activities. In this review, we focused on the therapeutics effects of ginger and its constituents in the diseases management, and its impact on genetic and metabolic activities.

Keywords: Ginger, anti-tumour activity, anti-microbial activity, neuro-protector effect

Introduction

Although, allopath based treatment is effective in diseases cure but also alters the various metabolic and molecular pathways. Since ancient time, medicinal plants and its constituents have been used for diseases management. Medicinal plants and its constituents such curcumin, black seed, olive fruits/leaves and dates shows a therapeutic role in diseases control via modulation of biological activities [1-3]. In Islam, herbs and its constituents have important value in diet and treatment of various diseases and Prophet Mohammed (PBUH) used various herbs including dates and Nigella sativa and also recommended various medicinal plants in the diseases cure [4]. Medicinal plants and their constituents show a vital effect in the diseases cure especially with properties of being antioxidant, anti-inflammatory, anti-diabetic and anti-tumour effect. Ginger, the rhizome of the Zingiber officinale is commonly consumed dietary condiments [5], generally considered to be safe [6] and used to cure various diseases (Figure 1). It also shows a role in cancer prevention by inactivating and activating various molecular pathways. In this review, we summarized the therapeutics role of ginger in diseases management via modulation of biological activities including anti-inflammatory and anti-oxidative activities together with regulation of genes mechanism of action.

Figure 1.

Figure 1

Ginger plant and roots.

Chemical structure of active constituents

Numerous active ingredients are present in ginger including terpenes and oleoresin which called ginger oil. Ginger also constitutes volatile oils approximately 1% to 3% and non-volatile pungent components oleoresin [7]. The major identified components from terpene are sesquiterpene hydrocarbons and phenolic compounds which are gingerol and shogaol [8] and lipophilic rhizome extracts, yielded potentially active gingerols, which can be converted to shogaols, zingerone, and paradol [9] (Figure 2).

Figure 2.

Figure 2

Chemical of structure of active ingredients of Ginger.

Mechanism of action of ginger in diseases management

Ginger, the rhizome of the Zingiber officinale, plays an important role in prevention of diseases (Table 1). But the exact mechanism of action in diseases management is not understood fully. It is thought that ginger act as anticancer due to various constituents such as vallinoids, viz. [6]-gingerol and [6]-paradol, shogaols, zingerone, and galanals A and B [10-12] and constituents show a therapeutics role in diseases control via modulation of various biological activities as describe as following:

Table 1.

Showing biological activities of ginger active compounds

Active compound of ginger Biological activities References
Gingerol and gingerol related compound The antioxidant activity. [90]
Anti-tumour activity via induction of apoptosis, modulation of genetic and other biological activity. [91-94]
Anti-inflammatory and anti-analgesic activity. [95]
Anti-microbial activity. [96]
Hepato-protective activity. [97,98]
Paradol Anti-oxidant and anti-cancerous activity. [99-101]
Anti-microbial activity. [102]
Shogoal Anti-oxidant and anti-inflammatory activity. [91]
[6]-shogaol showed anticancer activities through the inhibition of cell invasion reduction of matrix metalloproteinase-9 expression, anti-proliferation activity and anti-invasion. [52,103,104]
Zingerone Antioxidant activity. [105,106]
Anti-inflammatory action. [107,108]
Anti-bacterial activity. [109]
Zerumbone Anti-tumour activity. [110]
Anti-microbial activity. [111]
1-Dehydro-(10) gingerdione Regulation of inflammatory genes. [112]
Terpenoids Induce Apoptosis by activation of p53. [15]
Ginger flavonoids Antioxidant activity. [113]

1. Ginger and its constituents show antioxidant activity and prevent the damage of macromolecules, caused by the free radicals/oxidative stress.

2. Ginger and its constituents also show a vital role as anti-inflammatory processes. Earlier studies on in vitro investigations of ginger preparations and some isolated gingerol-related compounds showed that anti-inflammatory effects of ginger such as inhibition of COX [13] and inhibition of nuclear factor κB [14].

3. Ginger also acts as antitumor via modulation of genetic pathways such as activation tumour suppressor gene, modulation of apoptosis and inhibition of VEGF. Earlier study has shown that terpenoids, constituents of ginger induce apoptosis in endometrial cancer cells through the activation of p53 [15].

4. Ginger also shows antimicrobial and other biological activities due gingerol and paradol, shogaols and zingerone. An important finding showed that 10% ethanolic ginger extract was found to possess antimicrobial potential against pathogens [16].

Pharmalogical activities of ginger and its constituents

Ginger showed its importance as a medicine in Asian countries since ancient times. Pharmalogical activities of ginger and its constituents in health managements through modulation of various biological activities described as following:

Antioxidant activity

Antioxidants are substances that play a role in the neutralization of free radicals and oxidative stress. The free radical production is balanced by the antioxidative defense system of our body [17]. Any alterations between reactive oxygen species (ROS) generation and its neutralization by antioxidant defense [18,19] cause oxidative stress. Several plants and their constituents are rich source of antioxidant and play a significant role in prevention of disease progression process. Ginger is a source of a large number of antioxidants and also plays an important role in the reduction of the lipid oxidation and inhibits the pathogenesis of diseases (Figure 3). Previous study reported that ginger extract possesses antioxidative characteristics and shows a role in scavenge superoxide anion and hydroxyl radicals [20,21] and gingerol, inhibited ascorbate/ferrous complex induced lipid peroxidation in rat liver microsomes [22].

Figure 3.

Figure 3

Ginger and its constituents shows role in diseases prevention.

The essential oil and oleoresin of Zingiber officinale exhibited significant antioxidant and antimicrobial activities [23]. 6 Dehydroshogaol, 6-shogaol and 1-dehydro-6-gingerdione has shown potent inhibitors of nitric oxide (NO) synthesis in activated macrophages [24]. Another report in the favor of ginger as antioxidant showed that 6-shogaol has potent antioxidant properties which can be attributed to the presence of unsaturated ketone moiety [25]. Another study has shown that phenolic substances possess strong anti-inflammatory and antioxidative properties and considerable anticarcinogenic and antimutagenic activities [26] and showed role as in scavenging of H2O2, which donate electrons to H2O2, thus neutralizing it to water [27]. Earlier report showed that antioxidative activity of ginger extract in animal model [28].

Anti-inflammatory activity

Inflammation is a complex immune process and various mediators such as interleukin-1 (IL-1), tumour necrosis factor (TNF) and anti-inflammatory cytokines involve in this process. Currently non steroidal anti-inflammatory drugs are commonly used to treat the inflammation but this drug shows an adverse side effect and gastric ulcer. Various medicinal plants and their constituents have shown a vital effect in the prevention of inflammatory process. Earlier study has shown that ginger oil (33 mg/kg), administered orally to rats for 26 days, showed significant repression of paw and joint swelling associated with severe chronic adjuvant arthritis [29]. Ginger also shows a vital role in the suppression/inhibition in synthesis of pro-inflammatory cytokines such as IL-1, TNF-α, and IL-8 [13,30,31]. Another finding revealed that, the elevated expression of TNF-α in liver cancer rats was blocked when treated with ginger extract (100 mg/kg body weight) [32]. In addition to that, Ginger play a role in the inhibition of COX and 5-lipoxygenase, essential for arachidonate metabolism [33], and down-regulating the induction of inflammatory genes [34,35].

Earlier investigation has shown that, Ginger root and its constituents can inhibit NF-κB activation induced by a variety of agents [36-38] and downregulation of NF-κB gene products involved in cellular proliferation and angiogenesis [39]. DZO also shows a role in suppressing the expression of LPS-induced IFN-γ and IL-6, which are elevated in LPS-induced inflammation [40].

Anti-tumour activity

Tumour development and progressions are multi step process including genetic and metabolic changes [41,42]. Earlier study summarized the role of medicinal plant in the diseases management via modulation of various biological activities including cancer [43,44]. Ginger and its constituents show a vital effect in the control of tumour development through up regulation of tumour suppressor gene, induction of apoptosis and inactivation of VEGF pathways (Figure 4). Angiogenic factor such as VEGF play a significant role in the development and progression of tumour. Therefore, Inhibition of VEGF is an important step in the prevention of tumour development/management. Earlier investigation has shown that, 6-gingerol has role in the suppression of the transformation, hyperproliferation, and inflammatory processes that involve in various steps of carcinogenesis, angiogenesis and metastasis [45-48]. Another numerous studies showed that 6-gingerol, constituents of ginger play a role in the induction of apoptosis in the prostate cancer cell line LnCaP by increasing the expression of p53 and Bax and also decreasing the expression of Bcl-2 [49-51]. Another important study has shown that 6-shogaol show anticancer activities against breast cancer via inhibition of cell invasion reduction of matrix metalloproteinase-9 expression [52]. Another important finding suggest that 6-gingerol stimulates apoptosis through upregulation of NAG-1 and G1 cell cycle arrest through downregulation of cyclin D1 [53].

Figure 4.

Figure 4

Ginger and its constituent play pharmacological effect in cancer management via modulation of molecular mechanism.

An important study reported that ginger root extracts and gingerol play a significant role in inhibition of the growth of Helicobacter pylori CagA+ strains, which has a specific gene linked to the development of gastric premalignant and malignant lesions [54] Moreover, 6-shogaol has shown to induce apoptosis in human colorectal carcinoma cells via the production of reactive oxygen species and activation of caspase [31] and [6]-gingerol inhibited pulmonary metastasis in mice bearing B16F10 melanoma cells through the activation of CD8+ T cells [55]. Earlier finding has reported that 6-gingerol showed its anti-tumoral activity through induction of ROS which is also known to trigger activation of p53 and the cell cycle arrest and apoptosis [56]. Another important and first finding showed that in vitro and in vivo anticancer activity of whole GE for the management of prostate cancer [57].

Anti-microbial activity

Drug resistance is increasing worldwide and it is consider as a main culprit in the failure of treatment. The use of antibiotics against bacteria/microorganism is effective mode of treatment but also causes adverse complications. Earlier investigators have shown that, ginger and its constituents play a vital role in the prevention of microbial growth or acts as anti-microbial agents. An important study in the favors of ginger as anti-microbial activity showed that ginger has antimicrobial activity against E coli, Salmonella typhi and Bacillus subtilis and ethanolic extract of ginger showed widest zone of inhibition against Salmonella typhi [58]. Ginger rhizome contains several constituents which have antibacterial and anti fungal effects. The gingerol and shagelol are identified as more active agents [59]. Earlier studies have shown that, ginger has broad antibacterial activity and the ethanolic extract of ginger powder has pronounced inhibitory activities against Candida albicans [60-62] and other report also showed that antifungal properties of ginger extract, Gingerol [63]. Chief constituents such as [6]-gingerol and [12]-gingerol, isolated from ginger rhizome, showed antibacterial activity against periodontal bacteria [64] and [10]-gingerol has been reported as active inhibitor of M. avium and M. tuberculosis in vitro [65].

Anti-diabetic activity

Diabetes is a metabolic disorder and major global health problem worldwide. It is caused by abnormality of carbohydrate metabolism which is related to low blood insulin level or insensitivity of target organs to insulin [66]. As per estimation, one person is detected with diabetes every five second in the world whereas someone dies of it every 10 second [67]. Ginger and their constituents showed pivotal role in the control of diabetes and its complications via anti hyperglycemic effect. The exact mechanism of action of ginger in diabetes control is not fully understood but it might be due to the inhibition of oxidative stress and anti-inflammatory process.

An important finding based on in STZ treated-type 1 diabetic rat model reported that, oral administration of ethanolic extract of ginger significantly decrease fasting blood glucose level [68]. Earlier study reported that significant blood glucose lowering effect of ginger juice in diabetic and non-diabetic animals [69]. Another study has shown that a significant hypoglycemic activity in rats after administration of ginger extract [70].

Neuroprotective effect

Ginger and their constituents play a vital role as neuroprotector. The exact mechanism of action of ginger in this vista is not known fully. But it is thought ginger shows neuroprotector effect due to the phenolic and flavonoids compounds. An important study has shown that, 6-shogaol has neuroprotective effects in transient global ischemia via the inhibition of microglia [71]. Another finding in the support of ginger as neuroprotector suggests that, it exhibit neuroprotective effect by accelerating brain anti-oxidant defence mechanisms and down regulating the MDA levels to the normal levels in the diabetic rats [72]. A recent report on ginger juice showed that, ginger has protective effect by decreasing the LPO and increasing GSH, SOD, CAT, GPx, GST, GR and QR and protein level in treated rats [73].

Effect on osteoarthritis

Osteoarthritis is one of the leading causes of musculoskeletal pain and disability worldwide. Treatment of osteoarthritis based on anti-inflammatory drugs gives relief but also shows side effect and may cause gastric ulcer. Ginger shows a significant role in the treatment of osteoarthritis and also has important therapeutic importance in Ayurvedic and Unani medicine since ancient time. An important study on osteoarthritis (OA) patients of knee has revealed that, highly purified and standardized ginger extract had significant effect on reducing symptoms of OA of the knee [74]. Another report in the support of ginger showed that, ginger is effective as indomethacin in relieving symptoms of osteoarthritis with negligible side effects [75].

Gastroprotective effect

Peptic ulcer is a major problem worldwide in both sexes. Various factors including food ingredients, stress, Helicobacter pylori and drugs are responsible of gastric ulcer. Several medicinal plants and its constituents show anti-ulcer effect in various ways but the exact mechanism is not understood fully. Ginger and its constituents show a vital role in ulcer prevention via increasing mucin secretion. Earlier findings have shown anti-ulcerative effects of ginger in experimental gastric ulcer models [76,77]. Chief constituents of ginger such as [6]-gingerol and [6]-shogaol suppressed gastric contraction in situ and suppression by the [6]-shogaol was more intensive [78].

Anti-emetic effect

Ginger and its constituents show a significant effect on nausea and vomiting. Exact mechanism of action of ginger in nausea and vomiting is not clear but it is thought that such type of effect due to constituents present in ginger including gingerols, shogaols, and galanolactone and diterpenoid of ginger [79,80]. Studies based on animal model revealed that, ginger extract possesses antiserotoninergic and 5-HT3 receptor antagonism effects which play an important role in the etiology of postoperative nausea and vomiting [79-81]. A study in the favors of ginger role in nausea and vomiting indicating its effect and provide relief in severity in nausea and vomiting [82].

Hepato-protective effect

Earlier investigators based on experimental findings have shown that, ginger and its constituents play a significant role in hepato-protection. An important study on ginger showed its protective effect against the CCl4-induced hepatotoxicity [83]. Another report has shown that, administration of single dose of aqueous extract of ginger (200, 400 mg/kg prior to acetaminophen) was effective in preventing the acetaminophen-induced hepatotoxicity and also decreased ALT, AST and ALP levels and increased the activities of antioxidant enzymes levels in the liver [84]. Ginger is also useful in preventing the mancozeb-induced hepatotoxicity [85]. A recent report showed that, ginger is effective in reversing lead induced reduction in the liver weight, to increase plasma SOD and CAT activity, decrease LPx [86]. A recent report summarized the role of ginger in various types of diseases including diabetic liver, kidney, eye, and neural system complications [87].

Effect on migraine

An important study showed that administration of ginger powder at dose of 500-600 mg for 3-4 days with gap of 4 hours, showed relief from migraine attack [88].

Effect of ginger on eye

Ginger and its constituents show an important role in the management of diabetes and its related symptoms including retinopathy. Earlier report has shown that an extract of ginger with dose 0.1 and 1.0 mg/mL reduced CML-KLH and MGO-derived advanced glycation end products (AGE) products by 60%-80% and glucose-derived AGE products by 50%-60% [89].

Safety, efficacy and toxicity of ginger

Numerous plants and its constituents show an important therapeutic effect in the health management. Measurement of toxicity and lethal dose level is important before using in health management. Several studies were performed to check the safe dose in animal model study.The dose and toxicity of ginger has been checked and recommended by various earlier investigators. A study in this vista, showed that dose of 0.5-1.0 g of ginger powder ingested 2-3 times for periods of 3 months to 2.5 years did not cause any adverse effects [114]. Another study on animals showed that the doses of 2.5 gram/kg body weight were tolerated without any mortality. But, when the dose was increased to 3-3.5 gram/kg body weight then there was 10-30% mortality [115]. An important study showed that ginger extract with different dosages such as 100, 333 and 1000 mg/kg administered to pregnant rats for 10 days during the period of organogenesis caused neither maternal nor developmental toxicity [116]. Other study conducted in both male and female rats at the dosages of 500, 1000 and 2000 mg/kg body weight for 35 days and results proved that chronic administration of ginger was not associated with any mortalities and abnormalities in general conditions, behavior, growth, and food and water consumption [117].

Conclusions

Current mode of treatment based on synthetic drugs such as anti-inflammatory, anti-diabetic, chemotherapy and radiotherapy drugs for the treatment are effective but also shows adverse side effect. A safe, effective and inexpensive product is needed to control the diseases development via modulation of genetic, metabolic, anti-oxidant and other associated activity. Ginger shows an important effect in the suppression of NFkB, COX2, and LOX, induction of apoptosis, activation of tumour suppressor gene and also modulates various biological activities. Ginger and their constituents create optimism towards the novel therapeutic strategy. Future research should focus on clinical trials to investigate its effectiveness and their exact role in modulation of molecular pathways.

References

  • 1.Mohamed DA, Al-Okbi S. In vitro evaluation of antioxidant activity of different extracts of Phoenix dactylifera L. fruits as functional foods. Dtsch Lebensm Rundsch. 2005;101:305–308. [Google Scholar]
  • 2.Aldebasi YH, Aly SM, Rahmani AH. Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol. 2013;5:203–215. [PMC free article] [PubMed] [Google Scholar]
  • 3.Rahmani AH, Alzohairy MA, Khan MA, Aly SM. Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways. Evid Based Complement Alternat Med. 2014;2014:724658. doi: 10.1155/2014/724658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Al-Bukhari MI. In: The Collection of Authentic Sayings of Prophet Mohammad (peace be upon him), Division 71 on Medicine. 2nd ed. Al-Bukhari Sahi., editor. Ankara, Turkey: Hilal Yayinlari; 1976. [Google Scholar]
  • 5.Surh YJ. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res. 1999;428:305–27. doi: 10.1016/s1383-5742(99)00057-5. [DOI] [PubMed] [Google Scholar]
  • 6.Kaul PN, Joshi BS. Alternative medicine: Herbal drugs and their critical appraisal-part II. Prog Drug Res. 2001;57:1–75. [PubMed] [Google Scholar]
  • 7.Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, Feng MR, Brenner DE. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev. 2008;17:1930–1936. doi: 10.1158/1055-9965.EPI-07-2934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hasan HA, Rasheed Raauf AM, Abd Razik BM, Rasool Hassan BA. Pharmaceut Chemical Composition and Antimicrobial Activity of the Crude ExtractsIsolated from Zingiber Officinale by Different Solvents. Pharmaceute Anat Acta. 2012;3:184. [Google Scholar]
  • 9.Govindarajan VS. Ginger - chemistry, technology, and quality evaluation: part 2. Crit Rev Food Sci Nutr. 1982;17:189–258. doi: 10.1080/10408398209527348. [DOI] [PubMed] [Google Scholar]
  • 10.Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006 May 14;71:1397–1421. doi: 10.1016/j.bcp.2006.02.009. [DOI] [PubMed] [Google Scholar]
  • 11.Miyoshi N, Nakamura Y, Ueda Y, Abe M, Ozawa Y, Uchida K, Osawa T. Dietary ginger constituents, galanals A and B, are potent apoptosis inducers in Human T lymphoma Jurkat cells. Cancer Lett. 2003 Sep 25;199:113–119. doi: 10.1016/s0304-3835(03)00381-1. [DOI] [PubMed] [Google Scholar]
  • 12.Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007;45:683–690. doi: 10.1016/j.fct.2006.11.002. [DOI] [PubMed] [Google Scholar]
  • 13.Tjendraputra E, Tran VH, Biu-Brennan D, Roufogalis BD, Duke CC. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg Chem. 2001;29:156–163. doi: 10.1006/bioo.2001.1208. [DOI] [PubMed] [Google Scholar]
  • 14.Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005;8:125–132. doi: 10.1089/jmf.2005.8.125. [DOI] [PubMed] [Google Scholar]
  • 15.Liu Y, Whelan RJ, Pattnaik BR, Ludwig K, Subudhi E, Rowland H, Claussen N, Zucker N, Uppal S, Kushner DM, Felder M, Patankar MS, Kapur A. Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLoS One. 2012;7:e53178. doi: 10.1371/journal.pone.0053178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Giriraju A, Yunus GY. Assessment of antimicrobial potential of 10% ginger extract against Streptococcus mutans, Candida albicans, and Enterococcus faecalis: an in vitro study. Indian J Dent Res. 2013;24:397–400. doi: 10.4103/0970-9290.118356. [DOI] [PubMed] [Google Scholar]
  • 17.Shyur LF, Tsung JH, Chen JH, Chiu CY, Lo CP. Antioxidant Properties of Extracts from Medicinal Plants Popularly Used in Taiwan Oxidatative stress play a siginificant effect in the pathogenesis of various types of disease. Int J Appl Sci Eng. 2005;3:195–202. [Google Scholar]
  • 18.Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834–838. doi: 10.1007/s001250100529. [DOI] [PubMed] [Google Scholar]
  • 19.Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. doi: 10.2337/diabetes.54.6.1615. [DOI] [PubMed] [Google Scholar]
  • 20.Cao ZF, Chen ZG, Guo P, Zhang SM, Lian LX, Luo L, Hu WM. Scavenging effects of ginger on superoxide anion and hydroxyl radical. Chung-Kuo Chung Yao Tsa Chih. 1993;8:750–764. [PubMed] [Google Scholar]
  • 21.Krishnakantha TP, Lokesh BR. Scavenging of superoxide anions by spice principles. Indian J Biochem Biophys. 1993;30:133–134. [PubMed] [Google Scholar]
  • 22.Reddy AA, Lokesh BR. Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Mol Cell Biochem. 1992;111:117–124. doi: 10.1007/BF00229582. [DOI] [PubMed] [Google Scholar]
  • 23.Bellik Y. Total antioxidant activity and antimicrobial potency of the essential oil and oleoresin of Zingiber officinale Roscoe. Asian Pac J Trop Dis. 2014;4:40–44. [Google Scholar]
  • 24.Li F, Wang Y, Parkin KL, Nitteranon V, Liang J, Yang W, Li Y, Zhang G, Hu Q. Isolation of quinone reductase (QR) inducing agents from ginger rhizome and their in vitro anti-inflammatory activity. Food Res Int. 2011;44:1597–1603. [Google Scholar]
  • 25.Dugasani S, Pichika MR, Nadarajah VD, Balijepalli MK, Tandra S, Korlakunta JN. Comparative antioxidant and anti-inflammatory effects of [6] -gingerol, [8] -gingerol, [10] -gingerol and [6] -shogaol. J Ethnopharmacolo. 2010;127:515–520. doi: 10.1016/j.jep.2009.10.004. [DOI] [PubMed] [Google Scholar]
  • 26.Khader M, Bresgen N, Eckl PM. Antimutagenic effects of ethanolic extracts from three Palestinian medicinal plants. J Ethnopharmacol. 2010;127:319–24. doi: 10.1016/j.jep.2009.11.001. [DOI] [PubMed] [Google Scholar]
  • 27.Halliwell B, Gutteridge JMC. Free Radical in Biology and Medicine. Oxford, UK: Oxford University Press; 1985. [Google Scholar]
  • 28.Al-Tahtawy RHM, El-Bastawesy AM, Abdel Monem MG, Zekry ZK, Al-Mehdar HA, El-Merzabani MM. Antioxidant activity of the volatile oils of Zingiber officinale (ginger) Spatula DD. 2011;1:1–8. [Google Scholar]
  • 29.Sharma JN, Srivastava KC, Gan EK. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology. 1994;49:314–8. doi: 10.1159/000139248. [DOI] [PubMed] [Google Scholar]
  • 30.Verma SK, Singh M, Jain P, Bordia A. Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. Indian J Exp Biol. 2004;42:736–8. [PubMed] [Google Scholar]
  • 31.Pan MH, Hsieh MC, Kuo JM, Lai CS, Wu H, Sang S, Ho CT. [6] -Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res. 2008;52:527–37. doi: 10.1002/mnfr.200700157. [DOI] [PubMed] [Google Scholar]
  • 32.Habib SH, Makpol S, Abdul Hamid NA, Das S, Ngah WZ, Yusof YA. Ginger Extract (Zingiber Officinale) has Anti-Cancer and Anti-Inflammatory Effects on Ethionine-Induced Hepatoma Rats. Clinics. 2008;63:807–813. doi: 10.1590/S1807-59322008000600017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo) 1992;40:387–391. doi: 10.1248/cpb.40.387. [DOI] [PubMed] [Google Scholar]
  • 34.Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46:409–420. doi: 10.1016/j.fct.2007.09.085. [DOI] [PubMed] [Google Scholar]
  • 35.Tripathi S, Bruch D, Kittur DS. Ginger extract inhibits LPS induced macrophage activation and function. BMC Complement Altern Med. 2008;8:1–7. doi: 10.1186/1472-6882-8-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Aktan F, Henness S, Tran VH, Duke CC, Roufogalis BD, Ammit AJ. Gingerol metabolite and a synthetic analogue Capsarol inhibit macrophage NF-kappaB-mediated iNOS gene expression and enzyme activity. Planta Med. 2006;72:727–734. doi: 10.1055/s-2006-931588. [DOI] [PubMed] [Google Scholar]
  • 37.Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene. 2005;24:6957–6969. doi: 10.1038/sj.onc.1208845. [DOI] [PubMed] [Google Scholar]
  • 38.Kim SO, Chun KS, Kundu JK, Surh YJ. Inhibitory effects of [6] -gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin. Biofactors. 2004;21:27–31. doi: 10.1002/biof.552210107. [DOI] [PubMed] [Google Scholar]
  • 39.Nonn L, Duong D, Peehl DM. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Carcinogenesis. 2007;28:1188–96. doi: 10.1093/carcin/bgl241. [DOI] [PubMed] [Google Scholar]
  • 40.Choi YY, Kim MH, Hong J, Kim S, Yang WM. Dried Ginger (Zingiber officinalis) Inhibits Inflammation in a Lipopolysaccharide-Induced Mouse Model. Evid Based Complement Alternat Med. 2013;2013:914563. doi: 10.1155/2013/914563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rahmani A, Alzohairy M, Mandal AK, Rizvi MA. Expressional Evaluation of Androgen Receptor in Transitional Cell Carcinoma of Urinary Bladder Patients. Brit J Med Med Res. 2011;1:233–238. [Google Scholar]
  • 42.Rahmani A, Alzohairy M, Khadri H, Mandal AK, Rizvi MA. Expressional evaluation of vascular endothelial growth factor (VEGF) protein in urinary bladder carcinoma patients exposed to cigarette smoke. Int J Clin Exp Pathol. 2012;5:195–202. [PMC free article] [PubMed] [Google Scholar]
  • 43.Rahmani AH, Aly SM, Ali H, Babiker AY, Srikar S, Khan AA. Therapeutic effects of date fruits (Phoenix dactylifera) in the prevention of diseases via modulation of anti-inflammatory, antioxidant and anti-tumour activity. Int J Clin Exp Med. 2014;7:483–491. [PMC free article] [PubMed] [Google Scholar]
  • 44.Rahmani AH, Albutti AS, Aly SM. Therapeutics role of olive fruits/oil in the prevention of diseases via modulation of anti-oxidant, anti-tumour and genetic activity. Int J Clin Exp Med. 2014;7:799–808. [PMC free article] [PubMed] [Google Scholar]
  • 45.Bode AM, Ma WY, Surh YJ, Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6] -gingerol. Cancer Res. 2001;61:850–3. [PubMed] [Google Scholar]
  • 46.Kim EC, Min JK, Kim TY, Lee SJ, Yang HO, Han S, Kim YM, Kwon YG. [6] -Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Com. 2005;335:300–308. doi: 10.1016/j.bbrc.2005.07.076. [DOI] [PubMed] [Google Scholar]
  • 47.Kim SO, Kundu JK, Shin YK, Park JH, Cho MH, Kim TY, Surh YJ. [6] -Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene. 2005;224:2558–2567. doi: 10.1038/sj.onc.1208446. [DOI] [PubMed] [Google Scholar]
  • 48.Lee HS, Seo EY, Kang NE, Kim WK. [6] -Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem. 2008;19:313–319. doi: 10.1016/j.jnutbio.2007.05.008. [DOI] [PubMed] [Google Scholar]
  • 49.Rhode J, Fogoros S, Zick S, Wahl H, Griffith KA, Huang J, Liu JR. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med. 2007;7:44. doi: 10.1186/1472-6882-7-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Shukla Y, Prasad S, Tripathi C, Singh M, George J, Kalra N. In vitro and in vivo modulation of testosterone mediated alterations in apoptosis related proteins by [6] -gingerol. Mol Nutr Food Res. 2007;51:1492–1502. doi: 10.1002/mnfr.200700197. [DOI] [PubMed] [Google Scholar]
  • 51.Nigam N, George J, Srivastava S, Roy P, Bhui K, Singh M, Shukla Y. Induction of apoptosis by [6] -gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a] P-induced mouse skin tumorigenesis. Cancer Chemother Pharmacol. 2010;65:687–96. doi: 10.1007/s00280-009-1074-x. [DOI] [PubMed] [Google Scholar]
  • 52.Ling H, Yang H, Tan SH, Chui WK, Chew EH. 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation. Br J Pharm. 2010;161:1763–77. doi: 10.1111/j.1476-5381.2010.00991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog. 2008;47:197–208. doi: 10.1002/mc.20374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Mahady GB, Pendland SL, Yun GS, Lu ZZ, Stoia A. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res. 2003;23:3699–702. [PMC free article] [PubMed] [Google Scholar]
  • 55.Suzuki F, Kobayashi M, Komatsu Y, Kato A, Pollard RB. Keishi-ka-kei-to, a traditional Chinese herbal medicine,inhibits pulmonary metastasis of B16 melanoma. Anticancer Res. 1997;17:873–8. [PubMed] [Google Scholar]
  • 56.Yang G, Zhong L, Jiang L, Geng C, Cao J, Sun X, Ma Y. Genotoxic effect of 6-gingerol on human hepatoma G2 cells. Chem Biol Interact. 2010 Apr 15;185:12–7. doi: 10.1016/j.cbi.2010.02.017. [DOI] [PubMed] [Google Scholar]
  • 57.Karna P, Chagani S, Gundala SR, Rida PC, Asif G, Sharma V, Gupta MV, Aneja R. Benefits of whole ginger extract in prostate cancer. Br J Nutr. 2012;107:473–84. doi: 10.1017/S0007114511003308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Azu N, Onyeagba R. Antimicrobial Properties Of Extracts Of Allium cepa (Onions) and Zingiber officinale (Ginger) On Escherichia coli, Salmonella typhi and Bacillus subtilis. The Internet Journal of Tropical Medicine. 2007;3:1–10. [Google Scholar]
  • 59.Atai Z, Atapour M, Mohseni M. Inhibitory effect of Ginger Extract on Candida Albicans. Am J Applied Sci. 2009;6:1067–1069. [Google Scholar]
  • 60.Chen IN, Chang CC, Ng CC, Wang CY, Shyu YT, Chang TL. Antioxidant and Antimicrobial Activity of Zingiberaceous Plants in Taiwan. Plants Foods Hum Nutr. 2008;63:15–20. doi: 10.1007/s11130-007-0063-7. [DOI] [PubMed] [Google Scholar]
  • 61.Ficker CE, Smith ML, Susiarti S, Leaman DJ, Irawati C, Arnason JT. Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo) J Ethnopharmacol. 2003;85:289–293. doi: 10.1016/s0378-8741(03)00009-6. [DOI] [PubMed] [Google Scholar]
  • 62.Chairgulprasert V, Prasertsongskun S, Wichaporn W. Chemical constituents of the essential oil and antibacterial activity of Zingiber wrayi var. halabala. Songklanakarin J Sci Technol. 2005;27:813–818. [Google Scholar]
  • 63.Ficker C, Smith ML, Akpagana K. Bioassay-guided isolation and identification of antifungal compounds from ginger. J Phytother Res. 2003;17:897–903. doi: 10.1002/ptr.1335. [DOI] [PubMed] [Google Scholar]
  • 64.Miri P, Bae J, Lee DS. Antibacterial activity of [10] -gingerol and [12] -gingerol isolated from ginger rhizome against periodontal bacteria. Phytothery Res. 2008;22:1446–1449. doi: 10.1002/ptr.2473. [DOI] [PubMed] [Google Scholar]
  • 65.Hiserodt RD, Franzblau SG, Rosen RT. Isolation of 6-, 8-, and 10-Gingerol from Ginger Rhizome by HPLC and Preliminary Evaluation of Inhibition of Mycobacterium avium and Mycobacterium tuberculosis . Agric Food Chem. 1998;46:2504–2508. [Google Scholar]
  • 66.Maiti R, Jana D, Das UK, Ghosh D. Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2004;92:85–91. doi: 10.1016/j.jep.2004.02.002. [DOI] [PubMed] [Google Scholar]
  • 67.Colagiuri R. Diabetes: A pandemic, a development issue or both? Expert Rev Cardiovasc Ther. 2010;8:305–9. doi: 10.1586/erc.10.12. [DOI] [PubMed] [Google Scholar]
  • 68.Ojewole JAO. Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytother Res. 2006;20:764–772. doi: 10.1002/ptr.1952. [DOI] [PubMed] [Google Scholar]
  • 69.Sharma M, Shukla S. Hypoglycaemic effect of ginger. J Res Indian Yoga Homoeop. 1977;12:127–130. [Google Scholar]
  • 70.Ahmed RS, Sharma SB. Biological studies on combined effects of garlic (Allium sativum Linn) and ginger (Zingiber officinale Roscoe) in albino rats. J Exp Biol. 1997;35:841–843. [PubMed] [Google Scholar]
  • 71.Ha SK, Moon E, Ju MS, Kim DH, Ryu JH, Oh MS, Kim SY. 6-Shogaol, a ginger product, modulates neuro inflammation: a new approach to neuroprotection. Neuropharmacology. 2012;63:211–23. doi: 10.1016/j.neuropharm.2012.03.016. [DOI] [PubMed] [Google Scholar]
  • 72.Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2011;49:893–7. doi: 10.1016/j.fct.2010.12.013. [DOI] [PubMed] [Google Scholar]
  • 73.Sharma P, Singh R. Neuroprotective Effect of Ginger Juice Against Dichlorvos and Lindane Induced Toxicity in Wistar Rats. Planta Med. 2011;77:122. [Google Scholar]
  • 74.Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001;44:2531–2538. doi: 10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  • 75.Haghighi A, Tavalaei N, Owlia MB. Effects of ginger on primary knee osteoarthritis. Indian J Rheumatol. 2006;1:3–7. [Google Scholar]
  • 76.al-Yahva MA, Rafatullah S, Mossa JS, Ageel AM, Parmar NS, Tariq M. Gastroprotective activity of gingerzingiber officinal rocs, in albino rats. Am J Chin Med. 1989;17:51–56. doi: 10.1142/S0192415X89000097. [DOI] [PubMed] [Google Scholar]
  • 77.Yamahara J, Mochizuki M, Rong HQ, Matsuda H, Fujimura H. The anti-ulcer effect in rats of ginger constituents. J Ethnopharmacol. 1988;23:299–304. doi: 10.1016/0378-8741(88)90009-8. [DOI] [PubMed] [Google Scholar]
  • 78.Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E. Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. J Pharmacobiodyn. 1984;7:13–18. doi: 10.1248/bpb1978.7.836. [DOI] [PubMed] [Google Scholar]
  • 79.Bhattarai S, Tran VH, Duke CC. The stability of gingerol and shogaol in aqueous solutions. J Pharm Sci. 2001;90:1658–1664. doi: 10.1002/jps.1116. [DOI] [PubMed] [Google Scholar]
  • 80.Huang Q, Iwamoto M, Aoki S. Anti-5-hydroxytryptamine3, effect of galanolactone, diterpenoid isolated from ginger. Chem Pharm Bull. 1991;39:397–399. doi: 10.1248/cpb.39.397. [DOI] [PubMed] [Google Scholar]
  • 81.Lumb AB. Mechanism of antiemetic effect of ginger. Anaesthesia. 1993;48:1118. doi: 10.1111/j.1365-2044.1993.tb07572.x. [DOI] [PubMed] [Google Scholar]
  • 82.Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol. 2001;97:577–82. doi: 10.1016/s0029-7844(00)01228-x. [DOI] [PubMed] [Google Scholar]
  • 83.Patrick-Iwuanyanwu KC, Wegwu MO, Ayalogu EO. Prevention of CCl4- induced liver damage by ginger, garlic and vitamin E. Pak J Biol Sci. 2007;10:617–621. doi: 10.3923/pjbs.2007.617.621. [DOI] [PubMed] [Google Scholar]
  • 84.Ajith TA, Hema U, Aswathy MS. Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food Chem Toxicol. 2007;45:2267–2272. doi: 10.1016/j.fct.2007.06.001. [DOI] [PubMed] [Google Scholar]
  • 85.Sakr SA. Ameliorative effect of ginger (Zingiber officinale) on mancozeb fungicide induced liver injury in albino rats. Aus J Basic Appl Sci. 2007;1:650–656. [Google Scholar]
  • 86.Khaki AA, Khaki A. Antioxidant effect of ginger to prevents lead-induced liver tissue apoptosis in rat. J Med Plants Res. 2010;4:1492–1495. [Google Scholar]
  • 87.Li Y, Tran VH, Duke CC, Roufogalis BD. Preventive and Protective Properties of Zingi- ber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review. Evid Based Complement Alternat Med. 2012;2012:516870. doi: 10.1155/2012/516870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol. 1990;29:267–73. doi: 10.1016/0378-8741(90)90037-t. [DOI] [PubMed] [Google Scholar]
  • 89.Saraswat M, Reddy PY, Muthenna P, Reddy GB. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. Brit J Nutr. 2009:1011714–1721. doi: 10.1017/S0007114508116270. [DOI] [PubMed] [Google Scholar]
  • 90.Masuda Y, Kikuzaki H, Hisamoto M, Nakatani N. Antioxidant properties of gingerol related compounds from ginger. Biofactors. 2004;21:293–6. doi: 10.1002/biof.552210157. [DOI] [PubMed] [Google Scholar]
  • 91.Park YJ, Wen J, Bang S, Park SW, Song SY. [6] -Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J. 2006;47:688–97. doi: 10.3349/ymj.2006.47.5.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Plengsuriyakarn T, Viyanant V, Eursitthichai V, Tesana S, Chaijaroenkul W, Itharat A, Na-Bangchang K. Cytotoxicity, toxicity, and anticancer activity of Zingiber officinale Roscoe against cholangiocarcinoma. Asian Pac J Cancer Prev. 2012;13:4597–606. doi: 10.7314/apjcp.2012.13.9.4597. [DOI] [PubMed] [Google Scholar]
  • 93.Hu R, Zhou P, Peng YB, Xu X, Ma J, Liu Q, Zhang L, Wen XD, Qi LW, Gao N, Li P. 6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress. PLoS One. 2012;7:e39664. doi: 10.1371/journal.pone.0039664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Kim HW, Oh DH, Jung C, Kwon DD. Apoptotic Effects of 6-Gingerol in LNCaP Human Prostate Cancer Cells Soonchunhyang. Med Sci. 2011;17:75–79. [Google Scholar]
  • 95.Young HY, Luo YL, Cheng HY, Hsieh WC, Liao JC, Peng WH. Analgesic and anti-inflammatory activities of [6] -gingerol. J Ethnopharmacol. 2005;96:207–310. doi: 10.1016/j.jep.2004.09.009. [DOI] [PubMed] [Google Scholar]
  • 96.Park M, Bae J, Lee DS. Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytother Res. 2008;22:1446–1449. doi: 10.1002/ptr.2473. [DOI] [PubMed] [Google Scholar]
  • 97.Alqasoumi S, Yusufoglu H, Farraj A, Alam A. Effect of 6-shogaol and 6-gingerol on Diclofenac Sodium Induced Liver Injury. Int J Pharmacol. 2011;7:868–873. [Google Scholar]
  • 98.Sabina EP, Pragasam SJ, Kumar S, Rasool M. 6-gingerol, an active ingredient of ginger, protects acetaminophen-induced hepatotoxicity in mice. Zhong Xi Yi Jie He Xue Bao. 2011;9:1264–9. doi: 10.3736/jcim20111116. [DOI] [PubMed] [Google Scholar]
  • 99.Chung WY, Jung YJ, Surh YJ, Lee SS, Park KK. Antioxidative and antitumor promoting effects of (6)-paradol and its homologs. Mutat Res. 2001;496:199–206. doi: 10.1016/s1383-5718(01)00221-2. [DOI] [PubMed] [Google Scholar]
  • 100.Suresh K, Manoharan S, Vijayaanand MA, Sugunadevi G. Chemopreventive and antioxidant efficacy of (6)-paradol in 7,12-dimethylbenz(a)anthracene induced hamster buccal pouch carcinogenesis. Pharmacol Rep. 2010 Nov-Dec;62:1178–85. doi: 10.1016/s1734-1140(10)70380-7. [DOI] [PubMed] [Google Scholar]
  • 101.Keum YS, Kim J, Lee KH, Park KK, Surh YJ, Lee JM, Lee SS, Yoon JH, Joo SY, Cha IH, Yook JI. Induction of apoptosis and caspase-3 activation by chemopreventive [6] -paradol and structurally related compounds in KB cells. Cancer Lett. 2002 Mar 8;177:41–7. doi: 10.1016/s0304-3835(01)00781-9. [DOI] [PubMed] [Google Scholar]
  • 102.Galal AM. Antimicrobial Activity of 6-Paradol and Related Compounds. Pharm Biol. 1996;34:64–69. [Google Scholar]
  • 103.Choudhury D, Das A, Bhattacharya A, Chakra- barti G. Aqueous extract of ginger shows antiproliferative activity through disruption of microtubule network of cancer cells. Food Chem Toxicol. 2010;48:2872–2880. doi: 10.1016/j.fct.2010.07.020. [DOI] [PubMed] [Google Scholar]
  • 104.Weng CJ, Wu CF, Huang HW, Ho CT, Yen GC. Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol Nutr Food Res. 2010;54:1618–1627. doi: 10.1002/mnfr.201000108. [DOI] [PubMed] [Google Scholar]
  • 105.Shin SG, Kim JY, Chung HY, Jeong JC. Zingerone as an antioxidant against peroxynitrite. J Agric Food Chem. 2005;53:7617–7622. doi: 10.1021/jf051014x. [DOI] [PubMed] [Google Scholar]
  • 106.Aeschbach R, Löliger J, Scott BC, Murcia A, Butler J, Halliwell B, Aruoma OI. Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol. 1994;32:31–36. doi: 10.1016/0278-6915(84)90033-4. [DOI] [PubMed] [Google Scholar]
  • 107.Chung SW, Kim MK, Chung JH, Kim DH, Choi JS, Anton S, Seo AY, Park KY, Yokozawa T, Rhee SH, Yu BP, Chung HY. Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats. J Med Food. 2009 Apr;12:345–50. doi: 10.1089/jmf.2007.0660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Kim MK, Chung SW, Kim DH, Kim JM, Lee EK, Kim JY, Ha YM, Kim YH, No JK, Chung HS, Park KY, Rhee SH, Choi JS, Yu BP, Yokozawa T, Kim YJ, Chung HY. Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol. 2010;45:419–26. doi: 10.1016/j.exger.2010.03.005. [DOI] [PubMed] [Google Scholar]
  • 109.Manjunatha JR, Bettadaiah BK, Negi PS, Srinivas P. Synthesis of quinoline derivatives of tetrahydrocurcumin and zingerone and evaluation of their antioxidant and antibacterial attributes. Food Chem. 2013 Jan 15;136:650–8. doi: 10.1016/j.foodchem.2012.08.052. [DOI] [PubMed] [Google Scholar]
  • 110.Kirana C, McIntosh GH, Record IR, Jones GP. Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone. Nutr Cancer. 2003;45:218–25. doi: 10.1207/S15327914NC4502_12. [DOI] [PubMed] [Google Scholar]
  • 111.Abdul AB, Abdelwahab SI, Al-Zubairi AS, Elhassan MM. Murali SMAnticancer and Antimicrobial Activities of Zerumbone from the Rhizomes of Zingiber zerumbut. Int J Pharmacol. 2008;4:301–304. [Google Scholar]
  • 112.Lee HY, Park SH, Lee M, Kim HJ, Ryu SY, Kim ND, Hwang BY, Hong JT, Han SB, Kim Y. 1-Dehydro-[10] -gingerdione from ginger inhibits IKKβ activity for NF-κB activation and suppresses NF-κB-regulated expression of inflammatory genes. Br J Pharmacol. 2012;167:128–140. doi: 10.1111/j.1476-5381.2012.01980.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Rahman S, Salehin F, Iqbal A. In vitro antioxidant and anticancer activity of young Zingiber officinale against human breast carcinoma cell lines. BMC Complement Altern Med. 2011;11:76. doi: 10.1186/1472-6882-11-76. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 114.Langner E, Greifenberg S, Gruenwald J. Ginger: History and use. Adv Ther. 1998;15:25. [PubMed] [Google Scholar]
  • 115.Srivastava KC. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomed Biochim Acta. 1984;43:S335–346. [PubMed] [Google Scholar]
  • 116.Weidner MS, Sigwart K. Investigation of the teratogenic potential of a Zingiber officinale extract in the rat. Reprod Toxicol. 2001;15:75–80. doi: 10.1016/s0890-6238(00)00116-7. [DOI] [PubMed] [Google Scholar]
  • 117.Rong X, Peng G, Suzuki T, Yang Q, Yamahara J, Li Y. A 35-day gavage safety assessment of ginger in rats. Regul Toxicol Pharmacol. 2009;54:118–23. doi: 10.1016/j.yrtph.2009.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Physiology, Pathophysiology and Pharmacology are provided here courtesy of e-Century Publishing Corporation

RESOURCES